In my previous post, I described the challenges of certification, accreditation, and federal approvals, and how software can have a huge impact on the speed and ease with which your team goes through the process. For forward-thinking laboratory and technical leaders, however, regulatory approvals can also offer an opportunity to make software improvements that will help your business respond to […]
Read More
In our previous recap of industry news, we looked at the exciting partnerships and collaborations driving change, C-Suite and Board additions, and mergers and acquisitions. The Molecular Diagnostic Industry continues to innovate and grow, with laboratories and other industry partners working together to expedite COVID-19 testing and advance the community’s knowledge of the coronavirus. At the same time, clinical labs […]
Read More
Certification, accreditation, and federal approvals are a vital part of the business of running a clinical diagnostic lab. Many laboratory managers assume it means miles of red tape and numerous roadblocks. But that’s not necessarily true. In fact, it can be a fantastic opportunity. If you approach it with the right mindset, you could make improvements that have a lasting […]
Read More
In my previous post, I described the complex challenges NGS Clinical Diagnostic laboratories face because of legacy software. To recap, these include limitations in usability and efficiency, higher costs than labs generally understand, the difficulties that arise when you need to replace key personnel, and the lack of specialized software expertise in internal development teams. For laboratory and technical leads […]
Read More
Laboratory and technical leads face a number of complex challenges when changes to an existing process are required. Whether they want to add new assays, tests or products, take advantage of new equipment, or scale throughput, these challenges can lead them to wonder: Are my legacy systems adequate? Can or should these legacy systems be further customized? Should we consider […]
Read More
Next-generation sequencing (NGS) clinical diagnostic labs are playing a key role in efforts to assess the spread of the COVID-19 virus and to develop a vaccine and therapeutics. At the same time, they continue to collaborate and innovate, develop breakthroughs, and advance patient outcomes. In this post, we look at a few standout examples. Exciting Partnerships & Collaborations Driving Change […]
Read More